NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus. [electronic resource]
Producer: 20150422Description: E590-601 p. digitalISSN:- 1097-0215
- Adjuvants, Immunologic -- pharmacology
- Antibody Formation
- Antigens, Neoplasm -- genetics
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cholesterol -- pharmacology
- Drug Combinations
- Fowlpox virus -- genetics
- Humans
- Melanoma -- immunology
- Membrane Proteins -- genetics
- Phospholipids -- pharmacology
- Saponins -- pharmacology
- Vaccination
- Vaccines, Synthetic -- immunology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.